| 【Company Research】Joinn Laboratories (6127 HK) – Taping global markets for sustainable long-term growth |
| 【Company Research】Venus Medtech (2500 HK) – Expect sales turnaround in 2023 |
| 【Company Research】Kintor Pharmaceutical (9939 HK) – To focus on dermatologic diseases |
| 【Company Research】CR Gas (1193 HK) – Expect 2023 profit rebound ahead; attractive valuation |
| 【Company Research】Simcere Pharmaceutical (2096 HK) – Innovative drug business continues to grow |
| 【Company Research】Great Wall Motor (2333 HK) – Awaiting new PHEVs |
| 【Company Research】UEG (467 HK) – A mixed bag; volume growth is still the key |
| 【Company Research】China Meidong Auto (1268 HK) – Lingering industry headwinds amid high valuation |
| 【Company Research】Mengniu Dairy (2319 HK) – Subpar growth target but good corporate governance practice could stabilize shareholders’ return |
| 【Company Research】Tongda (698 HK) – FY22 results below; GPM recovery on better product mix |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
